References
- SeersholmNKok-JensenAClinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiencyThorax19985342652689741368
- JanciauskieneSErikssonSCalleaFDifferential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsinHepatology20044051203121015486938
- JanciauskieneSMBalsRKoczullaRVogelmeierCKohnleinTWelteTThe discovery of ?1-antitrypsin and its role in health and diseaseRespir Med201110581129113921367592
- MahadevaRAtkinsonCLiZPolymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivoAm J Pathol2005166237738615681822
- ParmarJSMahadevaRReedBJPolymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysemaAm J Respir Cell Mol Biol200226672373012034572
- HubbardRCSellersSCzerskiDStephensLCrystalRGBiochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiencyJAMA19882609125912643261353
- American Thoracic Society; European Respiratory SocietyAmerican Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiencyAm J Respir Crit Care Med2003168781890014522813
- SilvermanEKSandhausRAClinical practice. Alpha1-antitrypsin deficiencyN Engl J Med2009360262749275719553648
- SeersholmNWenckerMBanikNDoes alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEur Respir J19971010226022639387950
- WenckerMFuhrmannBBanikNKonietzkoNLongitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitorChest2001119373774411243951
- LiebermanJAugmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting dataChest200011851480148511083705
- DirksenADijkmanJHMadsenFA randomized clinical trial of alpha(1)-antitrypsin augmentation therapyAm J Respir Crit Care Med19991605 Pt 11468147210556107
- DirksenAPiitulainenEParrDGExploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiencyEur Respir J20093361345135319196813
- KueppersFThe role of augmentation therapy in alpha-1 antitrypsin deficiencyCurr Med Res Opin201127357958821226542
- CazzolaMMacNeeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J2008312416e6918238951
- HorvathIHuntJBarnesPJExhaled breath condensate: methodological recommendations and unresolved questionsEur Respir J200526352354816135737
- KoczullaARNoeskeSHerrCAmbient temperature impacts on pH of exhaled breath condensateRespirology201015115515919947991
- SackUScheibeRWotzelMMultiplex analysis of cytokines in exhaled breath condensateCytometry A200669316917216496377
- MirandaEPerezJEkeowaUIA novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiencyHepatology20105231078108820583215
- BalsRBeisswengerCBlouquitSChinetTIsolation and air-liquid interface culture of human large airway and bronchiolar epithelial cellsJ Cyst Fibros20043Suppl 2495115463925
- JanciauskieneSZelvyteIJanssonLStevensTDivergent effects of alpha1-antitrypsin on neutrophil activation, in vitroBiochem Biophys Res Commun2004315228829614766206
- SurhoneLMTimpledonMTMarsekenSFNormality Test: Data Set, Normal Distribution, Random Variable, Model Selection, Interpretations of ProbabilityBetascript Publishing2010
- DickensJALomasDAWhy has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisDrug Des Devel Ther20115391405
- StockleyRABayleyDLUnsalIDowsonLJThe effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiencyAm J Respir Crit Care Med2002165111494149812045122
- KasaharaYTuderRMTaraseviciene-StewartLInhibition of VEGF receptors causes lung cell apoptosis and emphysemaJ Clin Invest2000106111311131911104784
- NitaIHollanderCWestinUJanciauskieneSMProlastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine releaseRespir Res200561215683545
- GadekJEKleinHGHollandPVCrystalRGReplacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjectsJ Clin Invest1981685115811657028785
- LomasDAElliottPRCarrellRWCommercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent componentEur Respir J19971036726759073003
- BoringLGoslingJChensueSWImpaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout miceJ Clin Invest199710010255225619366570
- BaggioliniMClark-LewisIInterleukin-8, a chemotactic and inflammatory cytokineFEBS Lett19923071971011639201
- CapocciaBJGregoryADLinkDCRecruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashionJ Leukoc Biol200884376076818550788
- MorimotoHHiroseMTakahashiMMCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen speciesCardiovasc Res200878355456218267955
- RouhaniFPaoneGSmithNKKreinPBarnesPBrantlyMLLung neutrophil burden correlates with increased pro-inflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiencyChest20001175 Suppl 1250S251S10843938
- BouttenADehouxMSSetaNCompartmentalized IL-8 and elastase release within the human lung in unilateral pneumoniaAm J Respir Crit Care Med199615313363428542140
- JanciauskieneSLarssonSLarssonPVirtalaRJanssonLStevensTInhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsinBiochem Biophys Res Commun2004321359260015358147
- PottGBChanEDDinarelloCAShapiroLAlpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole bloodJ Leukoc Biol200985588689519197072
- BerginDAReevesEPMeleadyP?-1 antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8J Clin Invest2010120124236425021060150
- SapeyEStockleyJAGreenwoodHBehavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201118391176118621257786